Bio-clinical Evolutive Dynamic in Patients Suffering From Communitary Septic Shock (Biosepsis) (BIOSEPSIS)
This study has been completed.
Information provided by (Responsible Party):
AdministrateurDRC, University Hospital, Grenoble
First received: July 8, 2010
Last updated: January 16, 2015
Last verified: August 2012
Septic shock is a frequent pathology responsible for over 30000 deaths/year in France. Its outcome has not been improved despite the knowledge on inflammatory processes; a reason for these lack of results may lay on the lack of data on the precise dynamics of inflammatory and anti-inflammatory cascades and their consequences. We intend to achieve accurate monitoring of the inflammatory process on a small group of non-immunocompromised patients. Our goal is to obtain quality data, repeated over time, by limiting the technical variability.
Immunocompetent Patient on Septic Shock
||Observational Model: Cohort
Time Perspective: Prospective
||Bio-clinical Evolutive Dynamic in Patients Suffering From Communitary Septic Shock (Biosepsis)
Primary Outcome Measures:
- Evolutive profile of the inflammatory response during septic shock [ Time Frame: Hospitalisation in ICU ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
Secondary Outcome Measures:
- Research for early prognosis factors [ Time Frame: Hospitalisation in ICU ] [ Designated as safety issue: No ]
hormons, inflammatory markers, vitamines recovered from the patients serum.
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||October 2012 (Final data collection date for primary outcome measure)
The aim is to obtain precise data on the dynamics of cytokines, oxydative stress and hormonal response on immunocompetent adults during septic shock.
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
All immunocompetent patients hospitalised in intensive care from the beginning of the septic shock state.
- Patient over 18 years admitted in ICU.
- Clinical evidence of infection, suspected or proved, during the 48hrs following the hospital entry.
- Systemic inflammatory response syndrome.
- Shock defined as arterial hypotension (<90mmHg)not responding to adequated filling.
- Patient under guardianship or trusteeship
- Pregnant or lactating women
- Not affiliated to the social security
- Deprived of liberty by court decision
- Patients hospitalised without their approval
- Shock related to another cause than infection
- Long term corticothérapy
- On-going chemiothérapy, AIDS
- Bedridden patient
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01668329
|University Hospital Grenoble
|Grenoble, France, 38043 |
University Hospital, Grenoble
||TIMSIT Jean FRANCOIS, PU/PH
||University Hospital, Grenoble
No publications provided
||AdministrateurDRC, Pr JF TIMSIT, University Hospital, Grenoble
History of Changes
|Other Study ID Numbers:
|Study First Received:
||July 8, 2010
||January 16, 2015
||France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Keywords provided by University Hospital, Grenoble:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on June 30, 2015
Systemic Inflammatory Response Syndrome